CLBT vs FOUR Stock Comparison
CLBT currently leads FOUR in this stock comparison, with AIQ scores of 59 vs 56. The clearest difference is quality, while FOUR has the stronger value profile.
What is the main difference between CLBT and FOUR?
CLBT leads the current stock comparison as Cellebrite DI Ltd., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Cellebrite DI Ltd. vs Shift4 Payments, Inc.
CLBT leads
CLBT leads by 3 AIQ points, primarily on Quality and Risk Resilience.
Fragile: 2 of 5 evidence groups support CLBT, and its current signal state is conflicted.
Cellebrite DI Ltd.
Shift4 Payments, Inc.
The Algovestiq AIQ Score currently favors CLBT over FOUR, 59 versus 56 as of Nov 15, 2026. CLBT's advantage is driven primarily by stronger quality and risk resilience, while FOUR holds the stronger value profile. CLBT also shows the weaker technical structure relative to its 50-day moving average. 2 of 5 covered evidence groups favor CLBT today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 3 points. CLBT lead: Stable — the AIQ differential has held near 3 points over 30 sessions.
Compare Cellebrite DI Ltd. and Shift4 Payments, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare CLBT and FOUR against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality72 vs 51CLBT +21
- Value56 vs 75FOUR +19
- Risk Resilience50 vs 39CLBT +11
- Momentum54 vs 55Even
2 of 5 evidence groups favor CLBT. CLBT’s edge is concentrated in quality and risk resilience; FOUR keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +3
New signals
- Accumulation Pattern — bullish, volume, medium horizon (2.48x)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.3%)
- Volume Surge - Bullish — bullish, volume, short horizon (2.48x)
Largest factor move: Momentum +3
New signals
- Accumulation Pattern — bullish, volume, medium horizon (1.12x)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
CLBT's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — CLBT and FOUR both carry a full feed there.
The central trade-off
CLBT (Cellebrite DI Ltd.): the stronger current systematic profile, led by quality and risk resilience.
FOUR (Shift4 Payments, Inc.): the counter-case, on value, valuation, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CLBTCLBT on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CLBTCLBT on combined revenue and EPS growth.
Value
FOURFOUR on the peer-relative Value factor, by 19 points.
Momentum
EvenThe two are level on Momentum.
Lower downside
CLBTCLBT on Risk Resilience, by 11 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | CLBT | FOUR | Note |
|---|---|---|---|
| Implied upside to target | — | +25.9% | Level |
| Target dispersion | — | +60.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 8 | 25 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 5 covered evidence groups favor CLBT. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 59 vs 56 |
| Fundamentals | CLBT | revenue growth 13.6% vs 1.9%; EPS growth 3.3% vs 3.3%; TTM ROE 4.6% vs 2.6%; gross margin 82.3% vs 35.5%; operating margin 12% vs 8.2% |
| Valuation | FOUR | Value 56 vs 75 |
| Technicals | FOUR | Price vs 50-day -0.6% vs 11%; vs 200-day -12.6% vs -1.2% |
| Risk Resilience | CLBT | Risk Resilience 50 vs 39 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CLBT and FOUR and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 3 points. (argues the conclusion is provisional)
- Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CLBT.
How the comparison changed
120 daily snapshots · May 27 – Nov 13CLBT lead: Stable — the AIQ differential has held near 3 points over 30 sessions.
- Today
- CLBT +3
- 59 vs 56
- 7 sessions ago
- CLBT +1
- 54 vs 53
- 30 sessions ago
- CLBT +4
- 52 vs 48
- 90 sessions ago
- CLBT +7
- 55 vs 48
The lead changed hands 2 times in this window, most recently on Sep 23 when CLBT moved ahead of FOUR.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 3 bearish / 1 neutral, conflicted
Only CLBT
- Downtrend Structure Active — bearish, trend, long horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.3%)
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- Volume Surge - Bullish — bullish, volume, short horizon (2.48x)
3 bullish / 1 bearish / 2 neutral, conflicted
Only FOUR
- ADX Trend Weakening — neutral, trend, medium horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
Both carry 3 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode, Accumulation Pattern.
CLBT leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +5.88%, AIQ +2 points).
Price and the AIQ Score both moved up over the latest session (price +7.85%, AIQ +2 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1FOUR closes the Quality gap — currently 21 points behind, the largest single contributor to CLBT's edge.
- 2FOUR's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3CLBT's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
CLBT leads on balance| Metric | CLBT | FOUR |
|---|---|---|
| Revenue growth (YoY) | 13.6% | 1.9% |
| EPS growth (YoY) | 3.3% | 3.3% |
| Gross margin | 82.3% | 35.5% |
| Operating margin | 12% | 8.2% |
| Return on equity (TTM) | 4.6% | 2.6% |
| Debt to equity | 0.04 | 3.81 |
Performance
FOUR leads 4 of 6 windows| Metric | CLBT | FOUR |
|---|---|---|
| 1 week (5 sessions) | -7.4% | 1.9% |
| 1 month (20 sessions) | 4.5% | 13.6% |
| 3 months (63 sessions) | 10.4% | 1% |
| 6 months (126 sessions) | -11.2% | 6.6% |
| Year to date | -36.1% | -28.9% |
| 1 year (252 sessions) | -27.8% | -38.8% |
Technicals
FOUR has the stronger structure| Metric | CLBT | FOUR |
|---|---|---|
| RSI (14) | 45.2 | 59.5 |
| ADX (14) | 15.8 | 12.4 |
| Price vs 50-day | -0.6% | 11% |
| Price vs 200-day | -12.6% | -1.2% |
| Volatility (1M, annualized) | 61.1% | 60% |
Risk
CLBT is the more resilient| Metric | CLBT | FOUR |
|---|---|---|
| Beta | 0.69 | 1.28 |
| Sharpe ratio | -0.62 | -0.46 |
| Sortino ratio | -0.78 | -0.64 |
| Max drawdown | -45.9% | -51.8% |
| Current drawdown | -40.2% | -39.3% |
| Annualized volatility | 59.5% | 66% |
| Value at risk (95%) | -4.9% | -6.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CLBT or FOUR?
On the Algovestiq AIQ Score, CLBT is the stronger of the two as of Nov 15, 2026, scoring 59 against FOUR's 56. The edge comes from quality and risk resilience. FOUR is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CLBT or FOUR the better buy right now?
CLBT carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 3 points. Treat the lead as provisional.
Why does the AIQ Score favor CLBT over FOUR?
The composite weights Quality, Value, Momentum and Risk Resilience. CLBT leads Quality by 21 points; FOUR leads Value by 19 points; CLBT leads Risk Resilience by 11 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CLBT or FOUR?
Analyst price targets imply not covered upside for CLBT and +25.9% for FOUR. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CLBT or FOUR?
FOUR is the better-valued of the two on the peer-relative Value factor. FOUR on the peer-relative Value factor, by 19 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CLBT or FOUR?
CLBT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CLBT or FOUR?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CLBT or FOUR?
CLBT is the more resilient of the two, so the other name carries the higher downside risk. CLBT on Risk Resilience, by 11 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CLBT more profitable than FOUR?
CLBT leads on the comparable margin measures — gross margin 82.3% vs 35.5%; operating margin 12% vs 8.2%; ttm roe 4.6% vs 2.6%.
Is CLBT's lead over FOUR getting stronger or weaker?
CLBT lead: Stable — the AIQ differential has held near 3 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-09-23, when CLBT moved ahead of FOUR.
What would change the CLBT vs FOUR verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: FOUR closes the Quality gap — currently 21 points behind, the largest single contributor to CLBT's edge; FOUR's Death Cross Active resolves — a bearish trend rule currently active against it; CLBT's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about CLBT and FOUR?
CLBT: 3 bullish / 3 bearish / 1 neutral, conflicted. FOUR: 3 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CLBT is Death Cross Active (bearish, long horizon). On FOUR it is Death Cross Active (bearish, long horizon).
Compare CLBT and FOUR with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.